Copyright Reports & Markets. All rights reserved.

Global Human Combination Vaccines Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Human Combination Vaccines Market Overview

      • 1.1 Product Overview and Scope of Human Combination Vaccines
      • 1.2 Human Combination Vaccines Segment by Type
        • 1.2.1 Global Human Combination Vaccines Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Human Combination Inactivated Vaccines
        • 1.2.3 Human Combination Live Attenuated Vaccines
      • 1.3 Human Combination Vaccines Segment by Application
        • 1.3.1 Human Combination Vaccines Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.4 Global Human Combination Vaccines Market by Region
        • 1.4.1 Global Human Combination Vaccines Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Human Combination Vaccines Market Size
        • 1.5.1 Global Human Combination Vaccines Revenue (2014-2025)
        • 1.5.2 Global Human Combination Vaccines Production (2014-2025)

      2 Global Human Combination Vaccines Market Competition by Manufacturers

      • 2.1 Global Human Combination Vaccines Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Human Combination Vaccines Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Human Combination Vaccines Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Human Combination Vaccines Production Sites, Area Served, Product Types
      • 2.5 Human Combination Vaccines Market Competitive Situation and Trends
        • 2.5.1 Human Combination Vaccines Market Concentration Rate
        • 2.5.2 Human Combination Vaccines Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Human Combination Vaccines Production Market Share by Regions

      • 3.1 Global Human Combination Vaccines Production Market Share by Regions
      • 3.2 Global Human Combination Vaccines Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Human Combination Vaccines Production
        • 3.4.1 North America Human Combination Vaccines Production Growth Rate (2014-2019)
        • 3.4.2 North America Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Human Combination Vaccines Production
        • 3.5.1 Europe Human Combination Vaccines Production Growth Rate (2014-2019)
        • 3.5.2 Europe Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Human Combination Vaccines Production (2014-2019)
        • 3.6.1 China Human Combination Vaccines Production Growth Rate (2014-2019)
        • 3.6.2 China Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Human Combination Vaccines Production (2014-2019)
        • 3.7.1 Japan Human Combination Vaccines Production Growth Rate (2014-2019)
        • 3.7.2 Japan Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Human Combination Vaccines Consumption by Regions

      • 4.1 Global Human Combination Vaccines Consumption by Regions
      • 4.2 North America Human Combination Vaccines Consumption (2014-2019)
      • 4.3 Europe Human Combination Vaccines Consumption (2014-2019)
      • 4.4 China Human Combination Vaccines Consumption (2014-2019)
      • 4.5 Japan Human Combination Vaccines Consumption (2014-2019)

      5 Global Human Combination Vaccines Production, Revenue, Price Trend by Type

      • 5.1 Global Human Combination Vaccines Production Market Share by Type (2014-2019)
      • 5.2 Global Human Combination Vaccines Revenue Market Share by Type (2014-2019)
      • 5.3 Global Human Combination Vaccines Price by Type (2014-2019)
      • 5.4 Global Human Combination Vaccines Production Growth by Type (2014-2019)

      6 Global Human Combination Vaccines Market Analysis by Applications

      • 6.1 Global Human Combination Vaccines Consumption Market Share by Application (2014-2019)
      • 6.2 Global Human Combination Vaccines Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Human Combination Vaccines Business

      • 7.1 GlaxoSmithKline
        • 7.1.1 GlaxoSmithKline Human Combination Vaccines Production Sites and Area Served
        • 7.1.2 Human Combination Vaccines Product Introduction, Application and Specification
        • 7.1.3 GlaxoSmithKline Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Merck
        • 7.2.1 Merck Human Combination Vaccines Production Sites and Area Served
        • 7.2.2 Human Combination Vaccines Product Introduction, Application and Specification
        • 7.2.3 Merck Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sanofi
        • 7.3.1 Sanofi Human Combination Vaccines Production Sites and Area Served
        • 7.3.2 Human Combination Vaccines Product Introduction, Application and Specification
        • 7.3.3 Sanofi Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Daiichi Sankyo
        • 7.4.1 Daiichi Sankyo Human Combination Vaccines Production Sites and Area Served
        • 7.4.2 Human Combination Vaccines Product Introduction, Application and Specification
        • 7.4.3 Daiichi Sankyo Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Serum Institute of India
        • 7.5.1 Serum Institute of India Human Combination Vaccines Production Sites and Area Served
        • 7.5.2 Human Combination Vaccines Product Introduction, Application and Specification
        • 7.5.3 Serum Institute of India Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Takeda Pharmaceuticals
        • 7.6.1 Takeda Pharmaceuticals Human Combination Vaccines Production Sites and Area Served
        • 7.6.2 Human Combination Vaccines Product Introduction, Application and Specification
        • 7.6.3 Takeda Pharmaceuticals Human Combination Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served

      8 Human Combination Vaccines Manufacturing Cost Analysis

      • 8.1 Human Combination Vaccines Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Human Combination Vaccines
      • 8.4 Human Combination Vaccines Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Human Combination Vaccines Distributors List
      • 9.3 Human Combination Vaccines Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Human Combination Vaccines Market Forecast

      • 11.1 Global Human Combination Vaccines Production, Revenue Forecast
        • 11.1.1 Global Human Combination Vaccines Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Human Combination Vaccines Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Human Combination Vaccines Price and Trend Forecast (2019-2025)
      • 11.2 Global Human Combination Vaccines Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Human Combination Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Human Combination Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Human Combination Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Human Combination Vaccines Production, Revenue Forecast (2019-2025)
      • 11.3 Global Human Combination Vaccines Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Human Combination Vaccines Consumption Forecast (2019-2025)
        • 11.3.2 Europe Human Combination Vaccines Consumption Forecast (2019-2025)
        • 11.3.3 China Human Combination Vaccines Consumption Forecast (2019-2025)
        • 11.3.4 Japan Human Combination Vaccines Consumption Forecast (2019-2025)
      • 11.4 Global Human Combination Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Human Combination Vaccines Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are either combined in ready form or mixed before administration. Safety, efficacy, and immunogenicity of a combined immunizing agent are high.
        The increase in pediatric population is one of the primary growth factors for this market. With the increase in pediatric population, the demand for combination vaccines for immunization is higher as newborn infants are more vulnerable to various infectious diseases due to weak immune systems. These vaccines help reduce the number of shots and healthcare center visits, which consequently save time and money. It has been observed that the occurrence of viral infections and diseases such as polio, tetanus, diphtheria, smallpox, chickenpox, and measles is high among children in developing nations.
        The Americas is expected to be the major revenue contributor to the market by 2023. The introduction of strict regulatory norms that recommend proper vaccination of infants and the continuous efforts by vendors and national organizations to promote the use of human combination vaccines, will drive the market’s growth prospects in the Americas.

        The global Human Combination Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Human Combination Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Combination Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        GlaxoSmithKline
        Merck
        Sanofi
        Daiichi Sankyo
        Serum Institute of India
        Takeda Pharmaceuticals
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Human Combination Inactivated Vaccines
        Human Combination Live Attenuated Vaccines

        Segment by Application
        Hospitals
        Clinics
        Others

        Buy now